Phase I trial of neuropathic pain candidate successful [ + ]

Roche offers to buy out remaining Genentech shares for A$45 billion [ + ]

A new $30 million federal government-funded Cooperative Research Centre for Biomarker Translation (CRC-BT) has been launched at La Trobe University Research and Development Park. Core partners in the new CRC are La Trobe University and the Macfarlane Burnett Institute for Medical Research and Public Health in Melbourne; the Mater Medical Research Institute and Mater Health Services in Brisbane; and the Women & Children’s Health Research Institute and Institute of Medical and Veterinary Science in Adelaide. US-based biotechnology corporations Amgen and Becton Dickinson Biosciences are the commercial CRC-BT partners.

Swedish researchers track down the mutation that causes horses to go grey [ + ]

Researchers discover Lrh1 gene regulates and blocks ovulation [ + ]

Mediation and $20 million allows Biota and GSK to conclude litigation over Relenza [ + ]

Deloitte completes acquisition of Recombinant Capital [ + ]

Norwood Abbey subsidiary's technology to be evaluated by MedImmune [ + ]

HalcyGen completes recruitment for SUBA-Itraconazole trial [ + ]

Fossilomics research is being facilitated by the sensitivity, mass accuracy and resolution of modern mass spectrometry.

Mesoblast awarded extended patent for MPC stem cells [ + ]

More indications added to reimbursement schedule for PET imaging [ + ]

Funhaler sales up, CellSpray still on the shelf [ + ]

Neuren completes recruitment for Phase III trials for cognitive impairment [ + ]

Biosignal's anti-corrosion treatment under evaluation from ConocoPhillips [ + ]